期刊文献+

奥美拉唑碳酸氢钠干混悬剂杂质分析

Analysis of Impurities in Sodium Bicarbonate Dry Suspension
下载PDF
导出
摘要 目的:对奥美拉唑碳酸氢钠干混悬剂产生的杂质进行分析。方法:LC-MS法,辛烷基键合硅胶柱。结果:经LC-MS数据分析,奥美拉唑碳酸氢钠干混悬剂共产生5种杂质。结论:该方法能推断出样品中杂质的结构和来源。 Objective:To analyze the impurities produced by forced degradation of omeprazole sodium bicarbonate dry suspension.Methods:Silica gel column is bonded with octyl by LC-MS method.Results:By LC-MS spectrum analysis,5 impurities are produced of omeprazole sodium bicarbonate.Conclusion:This method can infer the structure and source of the impurities in the sample.
作者 潘丽 钟侃芷 PAN Li;ZHONG Kanzhi(Haikou Pharmaceutical Factory Co.,Ltd.,Haikou 570311,China)
出处 《品牌与标准化》 2024年第4期16-18,共3页
关键词 奥美拉唑碳酸氢钠 LC-MS 杂质分析 omeprazole sodium bicarbonate LC-MS impurity analysis
  • 相关文献

参考文献2

二级参考文献10

  • 1FDA. Guidance for Industry: Analytical procedures and methods validation, chemistry, manufacturing, and controls documentation (Draft) [S]. 2000.
  • 2ICH Q2A :Test on Validation of Analytical Procedures[S]. 2007.
  • 3ICH Q2B : Validation of Analytical Procedures : Methodology [ S ]. 2007.
  • 4ICH. Harmonized Tripartite Guideline: Impurities in New drug substances, Q3A (R). 2002: 1-10.
  • 5ICH. Harmonized Tripartite Guideline: Impurities in New drug substances, Q3B (R). 2003: 1-11.
  • 6FDA. Guidance for Industry Drug Product Chemistry, Manufacturing, and Controls Information [J/OL]. [2007-05-30]. http://www.fda.gov/cder/guidance.
  • 7EMEA. Guideline on the limits of genotoxic impurities [S/OL]. [2009-11-17]. http://www.emea.eu.int. TGA. Guidelines for the Registration of Drugs[S]. Vol.1, Appendix 10, 1994: 5-24.
  • 8TGA. Guidelines for the Registration of Drugs [S]. Vol.1, Appendix 10, 1994: 5-24.
  • 9国家食品药品监督管理局.化学药物杂质研究的技术指导原则[S].2005.
  • 10成海平.杂质检查分析方法建立过程中破坏性试验的意义和存在的问题分析[J].中国新药杂志,2008,17(17):1548-1549. 被引量:8

共引文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部